U.S. RESEARCH ROUNDUP-AT&T, ATI, California Resources

Accolade

01/07/2024 08:23

July 1 (Reuters) - Wall Street securities analysts revised their ratings and price
targets on several U.S.-listed companies, including AT&T, ATI and California Resources, on
Monday. 
    
    HIGHLIGHTS
    * AT&T Inc  T.N : JP Morgan adds stock to its u.s. analyst focus list 
    * ATI Inc  ATI.N : JP Morgan removes stock from its u.s. analyst focus list 
    * California Resources Corp  CRC.N : Gerdes Energy Research cuts to neutral from buy 
    * First Citizens Bancshares  FCNCA.O : JP Morgan adds stock to its u.s. analyst focus list 
                * Illumina Inc  ILMN.O : RBC cuts target price to $242 from $249 
 
        
Following is a summary of research actions on U.S. companies reported by Reuters on Monday.
Stock entries are in alphabetical order.
    
                 * Accolade Inc  ACCD.O : Stephens cuts target price to $10 from $14 
 
                 * Apellis Pharmaceuticals Inc  APLS.O : Mizuho cuts target price to $49 from $52 
 
                 * AT&T Inc  T.N : JP Morgan adds stock to its u.s. analyst focus list 
 
                 * ATI Inc  ATI.N : JP Morgan removes stock from its u.s. analyst focus list 
 
                 * California Resources Corp  CRC.N : Gerdes Energy Research cuts to neutral from buy 
 
                 * Central Garden & Pet Co  CENT.O : Canaccord Genuity cuts target price to $49 from $52 
 
                 * Coherus Biosciences Inc  CHRS.O : Baird cuts target price to $8 from $9 
 
                 * Elanco Animal Health Inc  ELAN.N : Piper Sandler cuts target price to $16 from $19 
 
                 * EQT Corp  EQT.N : Jefferies raises target price to $49 from $48 
 
                 * First Citizens Bancshares  FCNCA.O : JP Morgan adds stock to its u.s. analyst focus list 
 
                 * Hexcel Corp  HXL.N : Jefferies cuts target price to $70 from $72 
 
                 * Illumina Inc  ILMN.O : RBC cuts target price to $242 from $249 
 
                 * Insmed Inc  INSM.O : Truist Securities raises target price to $88 from $68 
 
                 * Kinetik Holdings Inc  KNTK.N : JP Morgan raises target price to $48 from $43 
 
                 * Nikola Corp  NKLA.O : TD Cowen adjusts PT to $10 from $0.5 to reflect 1-for-30 reverse stock split 
 
                 * Northern Oil and Gas Inc  NOG.N : Raymond James raises target price to $58 from $54 
 
                 * Ovintiv Inc  OVV.N : Jefferies cuts target price to $68 from $69 
 
                 * PTC Therapeutics Inc  PTCT.O : Jefferies cuts target price to $43 from $46 
 
                 * Rivian  RIVN.O : Canaccord Genuity raises target price to $30 from $20 
 
                 * Rivian  RIVN.O : RBC raises target price to $14 from $11 
 
                 * Rocket Pharmaceuticals Inc  RCKT.O : Leerink Partners cuts PT to $46 from $49 
 
                 * SM Energy Co  SM.N : Truist Securities cuts target price to $49 from $51 
 
                 * Spectrum Brands Holdings Inc  SPB.N : Canaccord Genuity cuts PT to $90 from $92 
 
                 * Taysha Gene Therapies Inc  TSHA.O : Piper Sandler cuts target price to $7 from $9 
 
                 * Walgreens  WBA.O : JP Morgan cuts target price to $20 from $30 
 
                 * Walgreens  WBA.O : TD Cowen cuts target price to $22 from $35 
 
   

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))